Predicting the effect of intravenous calcitriol on parathyroid gland activity using double-phase technetium Tc 99m-sestamibi scintigraphy

American Journal of Kidney Diseases

Volumn 44, Issue 3, 2004, Pages 476-480

  Torregrosa, Jose Vicente ^a   Fuster, David ^a   Ybarra, Juan ^a   Ortín, Jaime ^a   Moreno, Agustín ^a   Valveny, Neus ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b Infociencia Clinical Research   (Spain)

Author keywords

Calcitriol; secondary hyperparathyroidism (SHP); technetium Tc 99m sestamibi (MIBI)

Indexed keywords

CALCITRIOL; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; EVALUATION; FEMALE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PARATHYROID GLAND; PREDICTION; SCINTISCANNING; SECONDARY HYPERPARATHYROIDISM;

ADULT; AGED; CALCITRIOL; CALCIUM CHANNEL AGONISTS; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARATHYROID GLANDS; PARATHYROID HORMONE; PULSE THERAPY, DRUG; RADIOPHARMACEUTICALS; RENAL DIALYSIS; TECHNETIUM TC 99M SESTAMIBI;

EID: 4444351389     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2004.05.041     Document Type: Article

References (22)

1. D.L. Andress Intravenous versus oral vitamin D therapy in dialysis patients What is the question? Am J Kidney Dis 38 suppl 5 2001 S41 S44
2. G. Bacchini, F. Fabrizi, G. Pontoriero, D. Marcelli, S. Di Filippo, F. Locatelli 'Pulse oral' versus intravenous calcitriol therapy in chronic hemodialysis patients. A prospective and randomized study Nephron 77 1997 267 272
3. L.D. Quarles, D.A. Yohay, B.A. Carroll Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD Kidney Int 45 1994 1710 1721
4. M.-C. Monier-Faugere, H.H. Malluche Calcitriol pulse therapy in patients with end-stage renal failure Curr Sci 3 1994 615 619
5. Y. Tsukamoto, M. Nomura, Y. Takahashi The 'oral 1,25-dihydroxyvitamin D3 pulse therapy' in hemodialysis patients with severe secondary hyperparathyroidism Nephron 57 1991 23 28
6. G. Klaus, O. Mehls, J. Hinderer, E. Ritz Is intermittent oral calcitriol safe and effective in renal secondary hyperparathyroidism? Lancet 337 1991 800 801
7. J.V. Torregrosa, J.M. Campistol, M. Más, M. Montesinos, M.J. Martínez de Osaba Usefulness and pharmacokinetics of subcutaneous calcitriol in the treatment of secondary hyperparathyroidism Nephrol Dial Transplant 11 1996 54 57
8. H. Reichel, A. Szabo, J. Uhl Intermittent versus continuous administration of 1,25-dihydroxyvitamin D3 in experimental renal hyperparathyroidism Kidney Int 44 1993 1259 1265
9. R. Taillefer, Y. Boucher, C. Potvin, R. Lambert Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study) J Nucl Med 33 1992 1801 1807
10. I. Olaizola, J. Zingraff, C. Heuguerot [99mTc]-Sestamibi parathyroid scintigraphy in chronic haemodialysis patients Static and dynamic explorations Nephrol Dial Transplant 15 2000 1201 1206
11. 99mTc-MIBI and TL in a tumour cell line Nucl Med Commun 18 1997 235 240
12. 99mTc-sestamibi scintigraphy as a first-line imaging procedure in the preoperative evaluation of hyperparathyroidism Clin Endocrinol 43 1995 525 530
13. C.C. Chen, M.C. Skarulis, D.L. Fraker, H.R. Alexandre, S.J. Marx, A.M. Spiegel Technetium-99m-sestamibi imaging before reoperation for primary hyperparathyroidism J Nucl Med 36 1995 2186 2191
14. P. Ambrosoni, C. Heuguerot, I. Olaizola Can we use 99mTc-MIBI in functional studies of the parathyroid gland? Nephrol Dial Transplant 13 suppl 3 1998 S33 S36
15. D. Fuster, J. Ybarra, J.V. Torregrosa Double-phase parathyroid 99mTc-sestamibi scintigraphy in chronic haemodialysis patients Correlation with biochemical markers of parathyroid function Nucl Med Commun 24 2003 85 90
16. J.V. Torregrosa, L. Fernández-Cruz, A. Canalejo 99mTc-Sestamibi scintigraphy and cell cycle in parathyroid glands of secondary hyperparathyroidism World J Surg 24 2000 1386 1390
17. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease Am J Kidney Dis 42 suppl 3 2003 S1 S202
18. P. Ambrosoni, I. Olaizola, C. Heuguerot The role of imaging techniques in the study of renal osteodystrophy Am J Med Sci 320 2000 90 95
19. I. Olaizola, A. Aznarez, V. Jorgetti Are there any differences in the parathyroid response in the different types of renal osteodystrophy? Nephrol Dial Transplant 13 suppl 3 1998 S15 S18
20. F. Pons, J.V. Torregrosa, S. Vidal-Sicart Preoperative parathyroid gland localization with technetium-99m sestamibi in secondary hyperparathyroidism Eur J Nucl Med 24 1997 1494 1498
21. J.V. Torregrosa, M.R. Palomar, F. Pons Has double-phase MIBI scintigraphy usefulness in the diagnosis of hyperparathyroidism? Nephrol Dial Transplant 13 1998 37 40
22. A.K. Owda, D. Mousa, A.H. Abdallah Long-term intravenous calcitriol in secondary hyperparathyroidism The role of technetium-99m-MIBI scintigraphy in predicting the response to treatment Ren Fail 24 2002 165 173